Ropinirole Tablets In Young Patients With Restless Legs Syndrome
Status:
Completed
Trial end date:
2008-02-28
Target enrollment:
Participant gender:
Summary
This is a two-period dose rising study of Ropinirole Immediate Release in adolescent patients
with restless legs syndrome (RLS) in order to determine the starting dose for the ropinirole
titration regimen for this age group. Patients will receive two single doses unless poor
tolerability is observed following the first dose.